HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshifumi Kagamiishi Selected Research
Yoshifumi Kagamiishi Research Topics
Disease
3
Infarction (Infarctions)
07/2004 - 06/2002
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2004 - 06/2002
1
Parkinson Disease (Parkinson's Disease)
12/2018
1
Stroke (Strokes)
06/2006
1
Inflammation (Inflammations)
02/2006
1
Brain Ischemia (Cerebral Ischemia)
07/2004
1
Hypoxia (Hypoxemia)
01/2004
1
Ischemia
01/2004
1
Hypoglycemia (Reactive Hypoglycemia)
01/2004
1
Anxiety Disorders (Anxiety Disorder)
11/2003
1
Neurologic Manifestations (Neurological Manifestations)
06/2002
Drug/Important Bio-Agent (IBA)
2
Proteins (Proteins, Gene)
FDA Link
06/2006 - 02/2006
2
Enzymes
IBA
02/2006 - 06/2002
2
ONO2506
IBA
07/2004 - 06/2002
2
S100 Calcium Binding Protein beta Subunit
IBA
07/2004 - 06/2002
1
Prodrugs
IBA
12/2018
1
Carbidopa (Lodosyn)
FDA Link
Generic
12/2018
1
Levodopa (L Dopa)
FDA Link
Generic
12/2018
1
Glutamic Acid (Glutamate)
FDA Link
07/2004
1
Messenger RNA (mRNA)
IBA
07/2004
1
Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)
IBA
01/2004
1
Corticotropin-Releasing Hormone
IBA
01/2004
1
astressin
IBA
01/2004
1
Serotonin (5 Hydroxytryptamine)
IBA
11/2003
1
Biotin (Vitamin H)
FDA Link
06/2002
1
Glial Fibrillary Acidic Protein
IBA
06/2002
1
Cytokines
IBA
06/2002
1
triphosphoric acid (triphosphate)
IBA
06/2002
1
Monoclonal Antibodies
IBA
06/2002
1
Deoxyuridine
IBA
06/2002
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
06/2002
Therapy/Procedure
1
Intravenous Administration
06/2002